ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Clinical trials for ACUTE ON CHRONIC LIVER FAILURE (ACLF) explained in plain language.
Never miss a new study
Get alerted when new ACUTE ON CHRONIC LIVER FAILURE (ACLF) trials appear
Sign up with your email to follow new studies for ACUTE ON CHRONIC LIVER FAILURE (ACLF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can vitamin c save kidneys in liver failure patients?
Disease control Not yet recruitingThis study tests whether adding vitamin C to standard treatment can help patients with severe liver disease (ACLF) who have a serious infection (septic shock) and kidney injury. Vitamin C is a safe, cheap antioxidant that may reduce inflammation and protect the kidneys. The study…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated May 17, 2026 10:44 UTC
-
New blood filter could save lives in sudden liver failure
Disease control Not yet recruitingThis study tests a blood-filtering therapy called DPMAS for people with acute-on-chronic liver failure, a life-threatening condition where the liver suddenly stops working. About 56 adults will be randomly assigned to receive either standard care alone or standard care plus DPMAS…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated May 17, 2026 10:42 UTC
-
Pig liver trial offers hope for liver failure patients
Disease control Not yet recruitingThis early-stage study tests a genetically-modified pig liver (EGEN-5784) used outside the body with a special device to temporarily support liver function in 20 adults with acute-on-chronic liver failure. Participants are not eligible for a transplant. The goal is to check safet…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: PHASE1 • Sponsor: eGenesis, INC • Aim: Disease control
Last updated May 17, 2026 10:39 UTC
-
Liver dialysis breakthrough? new device could save lives in severe liver failure
Disease control Not yet recruitingThis study tests a device called DIALIVE 2.0, which acts like a dialysis machine for the liver, in people with acute-on-chronic liver failure (ACLF) grades 2-4. About 72 adults aged 18-70 with liver cirrhosis and recent worsening will either receive standard care or standard care…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: PHASE3 • Sponsor: Yaqrit Ltd • Aim: Disease control
Last updated May 17, 2026 10:26 UTC